During the past decade, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" #1 sponsor was "Charite University, Berlin, Germany" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "North Eastern German Society of Gynaecological Oncology" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "German Heart Institute" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" #1 collaborator was "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 2 trials as a collaborator, "ALL SCTped Forum" with 1 trials as a collaborator, "ALL-BFM Study Group" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are "Heart Failure" (3 trials), "Ovarian Cancer" (3 trials), "Crohn Disease" (2 trials), "Fallopian Tube Cancer" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (2 trials). Many other conditions were trialed in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" in a lesser frequency.

Most popular intervention types in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are "Drug" (22 trials), "Device" (7 trials), "Other" (6 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ustekinumab" (3 trials), "Fludarabine" (2 trials), "Macitentan" (2 trials) and "ABSORB Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum" are 35 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum". 2 are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".